sebi:WTM/RKA/EFD/139/2015

SEBI · SEBI · 2012-08-13 · Rajeev Kumar Agarwal, Whole Time Member

This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.

Facts / Headnote

Restrained and prohibited Ratna Drugs Limited from accessing the securities market and from buying, selling or dealing in securities, directly or indirectly, till it obtains SCORES authentication and resolves all pending investor grievances.

Provisions invoked

Parties

Holding

Ratna Drugs Limited is restrained and prohibited from accessing the securities market and from buying, selling or dealing in securities, directly or indirectly, in whatsoever manner, till it obtains SCORES authentication and resolves all investor grievances pending against it.

Full text

______________________________________________________________________________ In the matter of Ratna Drugs Limited Page 2 of 3

______________________________________________________________________________ In the matter of Ratna Drugs Limited Page 3 of 3

5. It was observed from the website of Ministry of Corporate Affairs (MCA) that there is no change in the registered office address of the company. Thereafter, on February 06, 2014 the SCN was served on the company by way of affixture at its registered office.

You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.

Free accounts include 10 searches/day with full order access.

Analyse this matter in Ontology · Plans

Source: SecMarx — sebi:WTM/RKA/EFD/139/2015. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.